skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 508  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Material Type:
Article
Add to My Research

Once-Weekly Semaglutide in Adults with Overweight or Obesity

The New England journal of medicine, 2021-03, Vol.384 (11), p.989-1002 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2032183 ;PMID: 33567185

Full text available

2
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
Material Type:
Article
Add to My Research

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

The Lancet (British edition), 2022-01, Vol.399 (10321), p.259-269 [Peer Reviewed Journal]

Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01640-8 ;PMID: 34895470

Full text available

3
Lipase Inhibitors for Obesity: A Review
Material Type:
Article
Add to My Research

Lipase Inhibitors for Obesity: A Review

Biomedicine & pharmacotherapy, 2020-08, Vol.128, p.110314, Article 110314 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved. ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2020.110314 ;PMID: 32485574

Full text available

4
Once-Weekly Semaglutide in Adolescents with Obesity
Material Type:
Article
Add to My Research

Once-Weekly Semaglutide in Adolescents with Obesity

The New England journal of medicine, 2022-12, Vol.387 (24), p.2245-2257 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2208601 ;PMID: 36322838

Full text available

5
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Material Type:
Article
Add to My Research

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

The New England journal of medicine, 2023-09, Vol.389 (10), p.877-888 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2302392 ;PMID: 37351564

Full text available

6
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Material Type:
Article
Add to My Research

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1808721 ;PMID: 30145941

Full text available

7
Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis
Material Type:
Article
Add to My Research

Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis

Annals of internal medicine, 2016-09, Vol.165 (6), p.409 [Peer Reviewed Journal]

ISSN: 1539-3704 ;EISSN: 1539-3704 ;DOI: 10.7326/M15-2455

Digital Resources/Online E-Resources

8
A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)
Material Type:
Article
Add to My Research

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

Obesity (Silver Spring, Md.), 2013-05, Vol.21 (5), p.935-943 [Peer Reviewed Journal]

Copyright © 2013 The Obesity Society ;Copyright © 2013 The Obesity Society. ;Copyright © 2013 The Obesity Society 2013 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.20309 ;PMID: 23408728

Full text available

9
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
Material Type:
Article
Add to My Research

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

The New England journal of medicine, 2010-07, Vol.363 (3), p.245-256 [Peer Reviewed Journal]

Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2010 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0909809 ;PMID: 20647200 ;CODEN: NEJMAG

Full text available

10
Drug interventions for the treatment of obesity in children and adolescents
Material Type:
Article
Add to My Research

Drug interventions for the treatment of obesity in children and adolescents

Cochrane database of systematic reviews, 2016-11, Vol.2020 (3), p.CD012436-CD012436 [Peer Reviewed Journal]

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD012436 ;PMID: 27899001

Full text available

11
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
Material Type:
Article
Add to My Research

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

The American journal of clinical nutrition, 2012-02, Vol.95 (2), p.297-308 [Peer Reviewed Journal]

2012 American Society for Nutrition. ;2015 INIST-CNRS ;Copyright American Society for Clinical Nutrition, Inc. Feb 1, 2012 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.3945/ajcn.111.024927 ;PMID: 22158731 ;CODEN: AJCNAC

Full text available

12
Efficacy and safety of orlistat in controlling the progression of prediabetes to diabetes: A meta-analysis and systematic review
Material Type:
Article
Add to My Research

Efficacy and safety of orlistat in controlling the progression of prediabetes to diabetes: A meta-analysis and systematic review

Medicine (Baltimore), 2024-05, Vol.103 (21), p.e38354-e38354 [Peer Reviewed Journal]

Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc. ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000038354 ;PMID: 38787971

Full text available

13
Antiobesity drug therapy
Material Type:
Article
Add to My Research

Antiobesity drug therapy

Cleveland Clinic journal of medicine, 2021-12, Vol.88 (12), p.657-657 [Peer Reviewed Journal]

ISSN: 0891-1150 ;EISSN: 1939-2869 ;DOI: 10.3949/CCJM.88C.12001 ;PMID: 34857599

Full text available

14
In Reply: Antiobesity drug therapy
Material Type:
Article
Add to My Research

In Reply: Antiobesity drug therapy

Cleveland Clinic journal of medicine, 2021-12, Vol.88 (12), p.657-658 [Peer Reviewed Journal]

ISSN: 0891-1150 ;EISSN: 1939-2869 ;DOI: 10.3949/ccjm.88c.12002 ;PMID: 34857600

Full text available

15
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
Material Type:
Article
Add to My Research

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

The journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.3067-3077 [Peer Reviewed Journal]

Copyright © 2011 by The Endocrine Society ;2015 INIST-CNRS ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2011-1256 ;PMID: 21795446 ;CODEN: JCEMAZ

Full text available

16
Effectiveness and safety of drugs for obesity
Material Type:
Article
Add to My Research

Effectiveness and safety of drugs for obesity

BMJ (Online), 2024-03, Vol.384, p.e072686-e072686 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2024BMJ ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2022-072686 ;PMID: 38527759

Full text available

17
Centrally Acting Agents for Obesity: Past, Present, and Future
Material Type:
Article
Add to My Research

Centrally Acting Agents for Obesity: Past, Present, and Future

Drugs (New York, N.Y.), 2018-07, Vol.78 (11), p.1113-1132 [Peer Reviewed Journal]

Springer International Publishing AG, part of Springer Nature 2018 ;Copyright Springer Science & Business Media Jul 2018 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-018-0946-y ;PMID: 30014268

Full text available

18
Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles
Material Type:
Article
Add to My Research

Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles

Diabetes, obesity & metabolism, 2016-06, Vol.18 (6), p.558-570

2016 John Wiley & Sons Ltd ;2016 John Wiley & Sons Ltd. ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12657 ;PMID: 26936802 ;CODEN: DOMEF6

Full text available

19
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Material Type:
Article
Add to My Research

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

The Lancet (British edition), 2007-11, Vol.370 (9600), p.1706-1713 [Peer Reviewed Journal]

Elsevier Ltd ;2007 Elsevier Ltd ;Copyright Elsevier Limited Nov 17-Nov 23, 2007 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(07)61721-8 ;PMID: 18022033 ;CODEN: LANCAO

Full text available

20
Wegovy: FDA approves weight loss drug to cut cardiovascular risk
Material Type:
Article
Add to My Research

Wegovy: FDA approves weight loss drug to cut cardiovascular risk

BMJ (Online), 2024-03, Vol.384, p.q642-q642 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2024BMJ ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.q642 ;PMID: 38479760

Full text available

Results 1 - 20 of 508  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (456)

Refine My Results

Creation Date 

From To
  1. Before 2001  (27)
  2. 2001 To 2005  (76)
  3. 2006 To 2010  (156)
  4. 2011 To 2016  (185)
  5. After 2016  (65)
  6. More options open sub menu

Resource Type 

  1. Articles  (503)
  2. magazinearticle  (4)
  3. Web Resources  (1)
  4. More options open sub menu

Language 

  1. English  (482)
  2. Japanese  (57)
  3. French  (12)
  4. Spanish  (8)
  5. Portuguese  (5)
  6. Swedish  (4)
  7. German  (3)
  8. Norwegian  (3)
  9. Italian  (1)
  10. Chinese  (1)
  11. More options open sub menu

Searching Remote Databases, Please Wait